Dacryocystosclerotherapy with doxycycline injection for chronic dacryocystitis: a case report
DOI:
https://doi.org/10.12809/hkjo-v26n2-338Keywords:
Dacryocystitis, DoxycyclineAbstract
We report a case of chronic dacryocystitis treated with dacryocystosclerotherapy with doxycycline injection in an 89-year-old woman. At the 12-month follow-up, the dacryocystitis was resolved, and there was a residual sac cavity with a trace amount of mucoid discharge without requiring further treatment.
References
1. Mills DM, Bodman MG, Meyer DR, Morton AD 3rd; ASOPRS Dacryocystitis Study Group. The microbiologic spectrum of dacryocystitis: a national study of acute versus chronic infection. Ophthalmic Plast Reconstr Surg 2007;23:302-6. DOI: https://doi.org/10.1097/IOP.0b013e318070d237
2. Mauriello JA Jr, Wasserman BA. Acute dacryocystitis: an unusual cause of life-threatening orbital intraconal abscess with frozen globe. Ophthal Plast Reconstr Surg 1996;12:294-5. DOI: https://doi.org/10.1097/00002341-199612000-00013
3. Sobel RK, Aakalu VK, Wladis EJ, Bilyk JR, Yen MT, Mawn LA. A comparison of endonasal dacryocystorhinostomy and external dacryocystorhinostomy: a report by the American Academy of Ophthalmology. Ophthalmology 2019;126:1580-5. DOI: https://doi.org/10.1016/j.ophtha.2019.06.009
4. Vasilakis M, Brouzas D, Charakidas A, Koukoulomatis P, Chatzoulis D. Dacryocystosclerotherapy. Ophthalmic Plast Reconstr Surg 2001;17:111-4. DOI: https://doi.org/10.1097/00002341-200103000-00006
5. Ali MJ, Dave TV, Mishra DK, Naik MN. Dacryocystosclerotherapy as an alternative to dacryocystectomy. Orbit 2019;38:300-4. DOI: https://doi.org/10.1080/01676830.2018.1544262
6. Pinar-Sueiro S, Sota M, Lerchundi TX, et al. Dacryocystitis: systematic approach to diagnosis and therapy. Curr Infect Dis Rep 2012. DOI: https://doi.org/10.1007/s11908-012-0238-8
7. Horbach SE, Lokhorst MM, Saeed P, de Goüyon Matignon de Pontouraude CM, Rothová A, van der Horst CM. Sclerotherapy for low-flow vascular malformations of the head and neck: a systematic review of sclerosing agents. J Plast Reconstr Aesthet Surg 2016;69:295-304. DOI: https://doi.org/10.1016/j.bjps.2015.10.045
8. Jacobson BF, Franz RC, Hurly EM, et al. Mechanism of thrombosis caused by sclerotherapy of esophageal varices using sodium tetradecyl sulphate. Surg Endosc 1992;6:4-9. DOI: https://doi.org/10.1007/BF00591179
9. Duffy DM. Sclerosants: a comparative review. Dermatol Surg 2010;36 Suppl 2:1010-25. DOI: https://doi.org/10.1111/j.1524-4725.2009.01469.x
10. Mann MW. Sclerotherapy: it is back and better. Clin Plast Surg 2011;38:475-87. DOI: https://doi.org/10.1016/j.cps.2011.02.006
11. Jin Y, Zou Y, Hua C, et al. Treatment of early-stage extracranial arteriovenous malformations with intralesional interstitial bleomycin injection: a pilot study. Radiology 2018;287:194-204. DOI: https://doi.org/10.1148/radiol.2017162076
12. Mack JM, Peterson EC, Crary SE, et al. Pharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations. Pediatr Blood Cancer 2022;69:e29733. DOI: https://doi.org/10.1002/pbc.29733
13. Lam SC, Yuen HKL. Medical and sclerosing agents in the treatment of orbital lymphatic malformations: what's new? Curr Opin Ophthalmol 2019;30:380-5. DOI: https://doi.org/10.1097/ICU.0000000000000585
14. Cheng J. Doxycycline sclerotherapy in children with head and neck lymphatic malformations. J Pediatr Surg 2015;50:2143-6. DOI: https://doi.org/10.1016/j.jpedsurg.2015.08.051
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Hong Kong Journal of Ophthalmology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Journal has a fully Open Access policy and publishes all articles under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. For any use other than that permitted by this license, written permission must be obtained from the Journal.
